4-(2-(4,5-DIHYDRO-3-METHYL-5-OXO-1H-PYRAZOL-4-YL)DIAZENYL)-1,2-DIHYDRO-1,5-DIMETHYL-2-PHENYL-3H-PYRAZOL-3-ONE
UNII S7M66W967F
Substance Identification & Data
This profile provides standardized clinical and technical data for 4-(2-(4,5-dihydro-3-methyl-5-oxo-1h-pyrazol-4-yl)diazenyl)-1,2-dihydro-1,5-dimethyl-2-phenyl-3h-pyrazol-3-one, uniquely identified by the FDA Unique Ingredient Identifier (UNII) S7M66W967F.
Technical mappings include the Chemical Abstracts Service (CAS) Registry Number 78439-24-4 and the RxNorm Concept ID (RxCUI) N/A. Explore the sections below for detailed nomenclature and a complete directory of NDC-listed products containing this ingredient.
Detailed Substance Profile
C15H16N6O2 RTRROIUHWKBNRP-ISLYRVAYSA-N Synonyms and Nomenclature
This section provides a complete list of nomenclature and identifier mappings for 4-(2-(4,5-dihydro-3-methyl-5-oxo-1h-pyrazol-4-yl)diazenyl)-1,2-dihydro-1,5-dimethyl-2-phenyl-3h-pyrazol-3-one. Identifiers are organized into official regulatory terms, commercial trade names, and technical systematic synonyms used to ensure accurate identification across clinical pharmaceutical databases, regulatory filings, and electronic health records.